author-photo

Glen Mikesell

6

Papers

35

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity.

2016 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (31)
Abstract A13: Anti-CD38-attenukine: A myeloma-targeting immunocytokine containing an engineered IFNα that provides >10,000-fold enhanced tumor-specific activity compared to native IFNα.

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)